PELVIC INFLAMMATORY DISEASE

This adverse event was reported 1493 times

These drugs are most commonly taken by patients reporting PELVIC INFLAMMATORY DISEASE:

# Drug Count
0 LEVONORGESTREL 610
1 COPPER 152
2 METRONIDAZOLE 79
3 DOXYCYCLINE 73
4 DOXYCYCLINE HYCLATE 73
5 IBUPROFEN 53
6 ACETAMINOPHEN 46
7 ETONOGESTREL AND ETHINYL ESTRADIOL 46
8 ADALIMUMAB 45
9 METRONIDAZOLE TOPICAL 45
See all common drugs associated with PELVIC INFLAMMATORY DISEASE

PELVIC INFLAMMATORY DISEASE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LACTULOSE SOLUTION USP, 10 G/15 ML 1 0.0099
1 TETRACAINE HYDROCHLORIDE 1 0.0075
2 ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE 1 0.0067
3 SERTACONAZOLE NITRATE 1 0.0062
4 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 1 0.0055
5 DIMETICONE 1 0.0035
6 COPPER 152 0.0035
7 MISOPROSTOL 34 0.0035
8 LEVONORGESTREL 610 0.0030
9 ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE 1 0.0027
See all drugs enriched for association with PELVIC INFLAMMATORY DISEASE

PELVIC INFLAMMATORY DISEASE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Copper-containing Intrauterine Device [EPC] 152 0.0031
1 Progestin [EPC] 662 0.0023
2 Prostaglandin E1 Analog [EPC] 34 0.0020
3 Guanylate Cyclase-C Agonist [EPC] 3 0.0014
4 Progestin Antagonist [EPC] 6 0.0013
5 Nitroimidazole Antimicrobial [EPC] 79 0.0012
6 Tetracycline-class Drug [EPC] 73 0.0010
7 Methylating Agent [EPC] 1 0.0010
8 Provitamin D2 Compound [EPC] 27 0.0009
9 Anti-anginal [EPC] 6 0.0006
See all drug classes enriched for association with PELVIC INFLAMMATORY DISEASE